[EN] PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS [FR] COMPOSES DE PYRROLE ET PYRAZOLE PRESENTANT UN EFFET POTENTIATEUR SUR LES RECEPTEURS DU GLUTAMATE
[EN] PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS [FR] COMPOSES DE PYRROLE ET PYRAZOLE PRESENTANT UN EFFET POTENTIATEUR SUR LES RECEPTEURS DU GLUTAMATE
Synthesis, Spectral Studies and C-S, C-N Bond Fissions of Some Novel N-[Alkyl (4′- Substituted Phenylthio)] Phthalimides
作者:Ali A. El-Bardan
DOI:10.1080/10426509808545492
日期:1998.2.1
n-butyl 3a-g derivatives have been synthesised. The structure of these compounds were proved by UV,IR, 1H NMR, 13CMR and mass spectra. The 1H and 13C chemicalshifts of the adjacentmethyleneprotons and carbons of both the sulfur atom and phthalimido nitrogen group were reasonably correlated using σ° values. The carbon-nitrogen and the carbon-sulfur bond fissions in alkaline and acidic media were discussed
Reacting Molecular Oxygen with Butanone under Visible Light Irradiation: A General Aerobic Oxidation of Alkenes, Sulfides, Phosphines, and Silanes
作者:Pengcheng Lian、Kaifeng Wang、Hang Liu、Ruyi Li、Minggang Li、Xiaoguang Bao、Xiaobing Wan
DOI:10.1021/acs.orglett.3c03096
日期:2023.11.10
technique by reacting molecularoxygen with butanone under visible lightirradiation. This method enables the mild oxidation of various functionalized compounds, including olefins, sulfides, phosphines, and silanes. Preliminary mechanistic experiments and theoretical calculations suggest that visible light triggers molecularoxygen to produce singlet oxygen in butanone. This singlet oxygen then reacts with
[EN] PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS<br/>[FR] COMPOSES DE PYRROLE ET PYRAZOLE PRESENTANT UN EFFET POTENTIATEUR SUR LES RECEPTEURS DU GLUTAMATE
申请人:LILLY CO ELI
公开号:WO2005040110A1
公开(公告)日:2005-05-06
The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.